Skip to main content
. 2018 May 3;11:147–156. doi: 10.2147/MDER.S130900

Figure 5.

Figure 5

COMPASS study design.

Note: Reproduced from Silberstein S, Winner PK, McAllister PJ, et al. Early onset of efficacy and consistency of response across multiple migraine attacks from the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan. Headache. 2017;57(6):862–876. © 2017 American Headache Society.34